Health Care Access Amendments

HB 519 prohibits pharmaceutical manufacturers from restricting 340B entities (like community health centers and safety-net hospitals) or pharmacies from accessing the 340B drug discount program. It bars manufacturers from denying drug access, imposing unnecessary data requirements, or interfering with contracts between pharmacies and 340B entities. The bill explicitly allows the Public Employees' Benefit Program to adjust practices to address financial impacts from these changes. This law directly affects providers relying on 340B discounts and ensures manufacturers cannot block their participation in the federal program.